Total Payments
$2,553
2024 Payments
$761.20
Companies
24
Transactions
83
Medicare Patients
572
Medicare Billing
$109,648
Payment Breakdown by Category
Food & Beverage$2,314 (90.6%)
Travel$239.46 (9.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,314 | 82 | 90.6% |
| Travel and Lodging | $239.46 | 1 | 9.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $397.56 | 21 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $308.99 | 6 | $0 (2024) |
| ABIOMED | $278.46 | 2 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $239.81 | 13 | $0 (2024) |
| Grifols USA, LLC | $215.20 | 6 | $0 (2024) |
| Gilead Sciences Inc | $202.07 | 2 | $0 (2017) |
| Actelion Pharmaceuticals US, Inc. | $124.99 | 1 | $0 (2024) |
| United Therapeutics Corporation | $124.99 | 1 | $0 (2017) |
| INOGEN, INC. | $98.96 | 5 | $0 (2024) |
| GENZYME CORPORATION | $76.21 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $761.20 | 24 | GlaxoSmithKline, LLC. ($190.41) |
| 2023 | $576.39 | 32 | GlaxoSmithKline, LLC. ($164.50) |
| 2022 | $205.43 | 13 | Grifols USA, LLC ($41.22) |
| 2021 | $94.00 | 5 | PENTAX of America, Inc. ($23.05) |
| 2019 | $278.46 | 2 | ABIOMED ($278.46) |
| 2018 | $75.16 | 1 | Janssen Pharmaceuticals, Inc ($75.16) |
| 2017 | $562.32 | 6 | Gilead Sciences Inc ($202.07) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiology | ||||||
| 07/25/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $21.65 | General |
| Category: HFCWO | ||||||
| 06/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Respiratory | ||||||
| 06/10/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $15.49 | General |
| Category: Medical Device | ||||||
| 05/23/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: IMMUNOLOGY | ||||||
| 05/16/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: IMMUNOLOGY | ||||||
| 05/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $110.90 | General |
| Category: DIABETES | ||||||
| 05/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Respiratory | ||||||
| 05/02/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $23.64 | General |
| Category: HFCWO | ||||||
| 04/24/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $5.33 | General |
| Category: IMMUNOLOGY | ||||||
| 04/18/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Pulmonology | ||||||
| 04/17/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $28.04 | General |
| Category: Respiratory | ||||||
| 04/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Respiratory | ||||||
| 04/16/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $9.43 | General |
| Category: IMMUNOLOGY | ||||||
| 03/21/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 03/20/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Respiratory | ||||||
| 03/19/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Inflammation | ||||||
| 03/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: IMMUNOLOGY | ||||||
| 03/04/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Respiratory | ||||||
| 02/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: RESPIRATORY | ||||||
| 02/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $28.83 | General |
| Category: IMMUNOLOGY | ||||||
| 01/25/2024 | INOGEN, INC. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $42.17 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 01/23/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 01/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $29.52 | General |
| Category: RESPIRATORY | ||||||
| 12/15/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 177 | 319 | $121,631 | $36,823 |
| 2022 | 6 | 185 | 281 | $94,419 | $32,129 |
| 2021 | 6 | 108 | 176 | $56,181 | $19,822 |
| 2020 | 4 | 102 | 170 | $53,324 | $20,874 |
Total Patients
572
Total Services
946
Medicare Billing
$109,648
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 47 | 123 | $72,834 | $20,058 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 44 | 76 | $18,314 | $6,683 | 36.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 26 | 28 | $12,650 | $3,335 | 26.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 22 | 33 | $6,873 | $2,862 | 41.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 38 | $5,155 | $2,128 | 41.3% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 12 | 21 | $5,805 | $1,757 | 30.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 35 | 77 | $45,596 | $13,167 | 28.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 43 | 68 | $16,364 | $6,171 | 37.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 34 | 46 | $8,756 | $3,702 | 42.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 24 | 24 | $10,842 | $3,671 | 33.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $7,699 | $3,177 | 41.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 23 | 40 | $5,162 | $2,241 | 43.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 21 | 60 | $33,358 | $10,385 | 31.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 28 | 40 | $9,570 | $3,958 | 41.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 17 | 21 | $3,997 | $1,706 | 42.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 14 | 14 | $3,627 | $1,626 | 44.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 12 | 24 | $3,097 | $1,356 | 43.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 17 | $2,531 | $790.67 | 31.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 27 | 67 | $31,017 | $11,701 | 37.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 25 | 25 | $9,353 | $3,963 | 42.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 24 | 47 | $6,987 | $2,672 | 38.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 26 | 31 | $5,967 | $2,538 | 42.5% |
About Dr. Kumar Shah, MD
Dr. Kumar Shah, MD is a Critical Care Medicine healthcare provider based in Buffalo, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1538351986.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kumar Shah, MD has received a total of $2,553 in payments from pharmaceutical and medical device companies, with $761.20 received in 2024. These payments were reported across 83 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,314).
As a Medicare-enrolled provider, Shah has provided services to 572 Medicare beneficiaries, totaling 946 services with total Medicare billing of $109,648. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Location Buffalo, NY
- Active Since 08/09/2007
- Last Updated 03/19/2024
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1538351986
Products in Payments
- Impella (Device) $278.46
- NUCALA (Biological) $228.19
- Letairis (Drug) $202.07
- FASENRA (Biological) $152.52
- TRELEGY ELLIPTA (Drug) $135.29
- JARDIANCE (Drug) $133.41
- DUPIXENT (Biological) $126.22
- Prolastin-C (Biological) $124.99
- UPTRAVI (Drug) $124.99
- TEZSPIRE (Biological) $91.05
- Prolastin-C Liquid (Biological) $90.21
- OFEV (Drug) $83.73
- INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) $81.87
- XARELTO (Drug) $75.16
- YUPELRI (Drug) $58.30
- AIRSUPRA (Drug) $49.00
- SMARTVEST (Device) $45.29
- GLASSIA (Biological) $41.83
- Hillrom - Life 2000 Ventilation System (Device) $28.99
- N/A (Device) $23.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Buffalo
Dr. Nashat Rabadi, Md, MD
Critical Care Medicine — Payments: $599,049
Critical Care Medicine $599,049
Dr. Francois Fadell, M.d, M.D
Critical Care Medicine — Payments: $4,467
Critical Care Medicine $4,467
Alberto Monegro, M.d, M.D
Critical Care Medicine — Payments: $1,847
Critical Care Medicine $1,847
Ann Steinwald, Np, NP
Critical Care Medicine — Payments: $1,495
Critical Care Medicine $1,495
Jessica Miller, Pa-C, PA-C
Critical Care Medicine — Payments: $1,328
Critical Care Medicine $1,328
Lucy Campbell, Md, MD
Critical Care Medicine — Payments: $195.92
Critical Care Medicine $195.92